Aretaieio Hospital, National and Kapodistrian University of Athens

Clinical research at Aretaieio Hospital, National and Kapodistrian University of Athens is exploring cardiovascular diseases, with a focus on atrial fibrillation that appears after stress such as surgery or acute illness. The work is aimed at improving stroke prevention and reducing broader vascular complications.

• Evaluating non-vitamin K oral anticoagulants for better protection against stroke and systemic embolism
• Assessing whether treatment can lower vascular death and other major thromboembolic events
• Studying the management of stress-related atrial fibrillation in real-world clinical settings

This area of research is designed to clarify how best to prevent serious cardiovascular outcomes in patients whose arrhythmia develops transiently during stressful medical events.

The site is also conducting trials in neoplasms, especially endometrial cancer with HER2 expression. These studies are focused on improving adjuvant treatment and measuring whether newer therapy options can extend disease-free survival compared with standard care.

• Comparing T-DXd with standard-of-care chemotherapy in HER2-expressing endometrial cancer
• Testing whether a targeted approach can improve disease-free survival after initial treatment
• Supporting better treatment selection for patients with endometrial malignancy linked to HER2

This research reflects a strong interest in refining cancer treatment strategies for patients with recurrent-risk gynecologic cancers and identifying more effective options than conventional therapy.